Pathstone Family Office, LLC Agenus Inc Transaction History

Pathstone Family Office, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 23, 2023	BUY	$2.02 - $3.25 $4 - $6	2 New	2 $0
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $4 - $6	2 New	2 $0
Q1 2021 May 14, 2021	SELL	$2.69 - $5.25 $5 - $10	-2 Closed	0 $0
Q1 2020 Jun 11, 2020	BUY	$1.92 - $4.39 $3 - $8	2 New	2 $0
Q4 2019 Feb 14, 2020	SELL	$2.41 - $4.4 $4 - $8	-2 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$2.51 - $3.73 $5 - $7	2 New	2 $0
Q2 2018 Aug 10, 2018	SELL	$2.26 - $4.65 $4 - $9	-2 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	2	2 $0

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.